ミエロイド・サーコマは,MAPK/ERK経路を活性化する変異の頻度が高く,クローナル血液形成と関連している
Dominik Nann1, Tim-Colin Schade1, Mathis Overkamp1
1Institute of Pathology and Neuropathology, University Hospital Tuebingen and Comprehensive Cancer Center South West, Tuebingen, Germany.
The journal of pathology. Clinical research
|September 4, 2025
まとめ
骨髄性肉腫 (MS) は,MAPK/ERK経路の変異と活性化を頻繁に表している. 遺伝分析により,高齢者のクローン進化とクローン造血との関連が明らかになった.
科学分野:
- 血液学
- 腫瘍学
- 分子生物学
背景:
- 骨髄性サーコマ (MS) は骨髄性ブラストの外側腫瘍である.
- MS,特に新しい症例に関する遺伝的データは限られています.
- 多発性硬化症の遺伝子を理解することは 診断と治療に不可欠です
研究 の 目的:
- 骨髄性サーコマの 遺伝子を調べるためだ
- 多発性硬化症の発生に伴う一般的な変異と経路を特定する.
- MSの遺伝的プロフィールと以前の骨髄性腫瘍とクローナル血液形成を比較する.
主な方法:
- 対象となる次世代シーケンシング (NGS) 41カ国のサンプル
- RNAベースの融合検出と遺伝子発現プロファイリング (GEP).
- 移植前と移植後の骨髄生検の分析
主要な成果:
- TET2,NPM1,NRASは最も頻繁に変異した遺伝子でした.
- MS患者の74%はMAPK/ ERK経路に変異があった.
- 前例の骨髄性腫瘍とクローン性血液形成と比較して,MSは独特の遺伝的変異を示した.
結論:
- 骨髄性肉腫はMAPK/ERK経路の変化が頻繁に見られる.
- MSではクローン進化とクローン血液形成が観察されています.
- 遺伝子プロファイリングは,MSの病原性と患者の層分化を理解するのに役立ちます.
関連する概念動画
MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cancers Originate from Somatic Mutations in a Single Cell
12.6K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.6K
Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Differentiation of Common Myeloid Progenitor Cells
3.3K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.3K


